Target intelligence / Profile preview

CRYGN antisense RNA 1 (CRYGN-AS1)

Target
CRYGN-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

CRYGN antisense RNA 1 (CRYGN-AS1) is a long non-coding RNA transcribed from the region antisense to the CRYGN gene. Antisense RNAs, including CRYGN-AS1, generally act by regulating the expression of their sense counterparts or neighboring genes, often through mechanisms such as transcriptional interference, RNase protection, chromatin remodeling, and interaction with promoter or enhancer regions. These mechanisms can modulate transcriptional activity, influence epigenetic imprinting, and affect mRNA processing or degradation. While antisense lncRNAs as a class play diverse roles in cellular biology and disease, there is currently no evidence that CRYGN-AS1 is a direct therapeutic target or that it has a defined role in any particular human disease.

02

Mechanism of action

Not applicable, as no drugs target CRYGN-AS1 directly. In general, antisense RNAs work by base pairing to sense mRNA to regulate translation or stability.

03

Biological functions

Gene regulation (positive and negative regulation of gene expression)Modulation of transcription through mechanisms such as transcriptional interference and chromatin modificationRegulation of methylation and imprinting patterns in some loci (as inferred from studies of antisense RNAs in general)

Beyond the preview

Go deeper on CRYGN antisense RNA 1 (CRYGN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRYGN antisense RNA 1 (CRYGN-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call